Trial NCT00098618

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02638
Secondary IDs: 6258-04-9R0 CDR0000398171 NCI-6553 U01CA099118

Last trial update was posted on 2013-07-02

MeSH Interventions

Interferon alpha-2 Interferon-alpha Interferons Sorafenib

MeSH Conditions

Carcinoma Carcinoma, Renal Cell

Other Conditions

Clear Cell Renal Cell Carcinoma Papillary Renal Cell Carcinoma Recurrent Renal Cell Cancer Stage III Renal Cell Cancer Stage IV Renal Cell Cancer

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID